Phosphate Buffer
Generic Name: phosphate buffer
Dosage form: SOLUTION. Active ingredients: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (443.6 mg/1); SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (24.1 mg/1). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: SOLUTION. Active ingredients: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (443.6 mg/1); SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (24.1 mg/1). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as solution.
Related Medications
Mogamulizumab-kpkc
mogamulizumab-kpkc
Chemokine Receptor Type 4 Interaction [EPC]
11 DESCRIPTION Mogamulizumab-kpkc is a recombinant humanized monoclonal antibody that targets CC chemokine receptor 4 (CCR4)-expressing cells. Mogamulizumab-kpkc is an IgG1 kappa immunoglobulin that has a calculated molecular mass of approximately 149 kDa. Mogamulizumab-kpkc is produced by recombinant DNA technology in Chinese hamster ovary cells.
Sunscreent
sunscreent
Sunscreen
Cupric Chloride
cupric chloride
DESCRIPTION Cupric chloride injection USP, 0.4 mg/mL is a sterile, clear, colorless to light blue color, nonpyrogenic solution intended for use as an additive to intravenous solutions for total parenteral nutrition (TPN). Each mL of solution contains 1.07 mg cupric chloride dihydrate; 9 mg sodium chloride and water for injection. The solution contains no bacteriostat, antimicrobial agent or added buffer.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.